Advertisement

Document › Details
Merck KGaA. (9/16/24). "Press Release: Merck and Siemens Enter Strategic Partnership on Digital Transformation Technology". Darmstadt.
![]() |
Organisation | Merck KGaA |
Group | Merck (DE) (Group) | |
Organisation 2 | Siemens AG | |
Group | Siemens (Group) | |
![]() |
Product | software |
Product 2 | automation equipment & systems (microelectronics/IT) | |
![]() |
Person | Beckmann, Kai (Merck KGaA 201709– Executive Board Member for Performance Materisl before Human Resources) |
Person 2 | Neike, Cedrik (Siemens 202409 CEO Digital Industries + Managing Board Member Siemens AG) | |
> Memorandum of Understanding signed to drive digital transformation through strategic projects across all three business sectors of Merck
> Siemens named one of the global preferred suppliers for Merck's next-level automation, boosting global smart manufacturing with Siemens Xcelerator platform
> Merck's cutting-edge production, enabled by Siemens, sets new standards in modular manufacturing
Merck, a leading science and technology company, and Siemens, a leading technology company deepened their mutual cooperation aimed at taking smart manufacturing to the next level today. Cedrik Neike, CEO Digital Industries and Member of the Managing Board of Siemens AG, and Kai Beckmann, CEO Electronics business and Member of the Executive Board of Merck, signed a Memorandum of Understanding (MoU) to expand cooperation in Smartfacturing (short for Smart Manufacturing) and outline the next steps for both companies. The MoU makes Siemens a preferred global supplier and strategic partner for Smartfacturing technologies, paving the way for transformative projects across Merck's three business sectors.
"Healthcare, Life Science, and Electronics are at the core of improving lives and creating a more sustainable future. By combining Merck’s expertise in these vital sectors with Siemens’ cutting-edge hardware and software we are transitioning from a concept of mass production to a modular approach, saving time and increasing flexibility. With the MoU, we now aim to set new global standards for future production,” said Cedrik Neike. “Our collaboration, which spans over 145 years, is a powerful reminder that Merck and Siemens are more than just partners - we are longstanding allies in shaping the future.”
Kai Beckmann highlighted the importance of this partnership: “Our goal is to bring new products to market faster, more cost-effectively, and with a heightened focus on sustainability. Smartfacturing is essential to achieving this, and Siemens is the perfect partner for this journey. Their deep domain expertise and century-long familiarity with Merck uniquely positions them to rapidly implement and scale our vision.”
Merck drives an ambitious digital transformation agenda. At the core of this development is the digital transformation of manufacturing, Smartfacturing. The MoU introduces a centralized governance structure to streamline decision-making and a contractual framework to fast-track the partnership agreement, opening doors to new business opportunities and industry-leading advancements. Central to this partnership is the Siemens Xcelerator platform, which will provide Merck with cutting-edge software and hardware solutions, enhancing their digital transformation efforts. One key element is modular production based on the plug & produce principle. This approach allows individual process modules to be added, removed, or reconfigured with ease, significantly reducing the time to market, lowering investment costs, and cutting CO2 emissions. The collaboration seeks to drive innovation, reduce complexity, and create growth for both companies.
A recent example of successful collaboration is the modular manufacturing line for GMP (Good Manufacturing Practice) production at Merck, based on the new automation standard MTP (Module Type Package), which ensures that the facility meets the highest standards of quality and safety, guaranteeing that every product manufactured adheres to rigorous industry requirements, ultimately safeguarding patient health and reinforcing Merck's commitment to excellence. Currently, Merck is utilizing this new automation technology for pharmaceutical and chemical production, but it can be applied to various production processes and manufacturing industries.
For more information, please contact Adrian Woitzik
+49 151 1454-7499
All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
About Merck
Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck generated sales of € 21 billion in 65 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.
Record changed: 2025-03-08 |
Advertisement

More documents for Merck (DE) (Group)
- [1] Merck KGaA. (2/18/25). "Press Release: New CEOs for Life Science and Healthcare Business Sectors and New Chief People Officer". Darmstadt....
- [2] Merck KGaA. (2/10/25). "Press Release: Merck Confirms Discussions with SpringWorks Therapeutics, Inc. on Potential Acquisition". Darmstadt....
- [3] Merck KGaA. (1/23/25). "Press Release: Merck Partners with Opentrons Labworks, Inc., Supporting Lab of the Future". Darmstadt....
- [4] Max Planck Innovation GmbH. (12/17/24). "Press Release: Christoph Hüls Becomes Managing Director of Max Planck Innovation GmbH, Succeeding Jörn Erselius, Who Is Retiring after more than 30 Years of Service"....
- [5] Merck KGaA. (12/17/24). "Press Release: Merck to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio". Darmstadt....
- [6] Single Use Support GmbH. (12/16/24). "Press Release: Darren Verlenden New CEO of Single Use Support". Kufstein....
- [7] Enara Bio Ltd.. (10/3/24). "Press Release: Enara Bio Raises $32.5 Million Series B Financing to Advance First-in-Class Pipeline of TCR-based Immunotherapies Targeting Novel Dark Antigens". Oxford....
- [8] Merck KGaA. (8/1/24). "Press Release: Merck Closes Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering". Darmstadt....
- [9] Merck KGaA. (7/24/24). "Press Release: Merck Signs MoU with Gene Therapy Research Institution". Tokyo....
- [10] ...
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top